Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Merakris Therapeutics, Inc.Merakris Therapeutics, Inc.
VS
RocheRoche
Merakris Therapeutics, Inc.

Merakris Therapeutics, Inc.

800 Park Offices Drive, Suite 403, Research Triangle Park, NC, US, 27709

Last Update: 03/04/2026

View Profile
Between 700 and 749
http://www.merakris.com
706/1000Moderate

A pioneer in biotechnology, Merakris Therapeutics, based in Research Triangle Park, North Carolina, is a leader in researching, developing, and marketing regenerative healthcare products. We are pioneering commercially scalable biotherapeutic technologies derived from s...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:27
Subsidiaries:0
12-month incidents
0
Known data breaches
1
Attack type number
1
Roche

Roche

Grenzacherstrasse, Switzerland 🇨🇭 , 4070, CH

Last Update: 28/06/2026

View Profile
Between 800 and 849
http://www.roche.com/
835/1000Good

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to ...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:103,689
Subsidiaries:51
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Merakris Therapeutics, Inc.

Merakris Therapeutics, Inc.

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Roche

Roche

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Merakris Therapeutics, Inc. in 2026.

Incidents

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Roche in 2026.

Incidents

Incident History - Merakris Therapeutics, Inc. (X = Date, Y = Severity)

Merakris Therapeutics, Inc. cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Roche (X = Date, Y = Severity)

Roche cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Merakris Therapeutics, Inc.

Merakris Therapeutics, Inc.

Incidents
🔒 Incident : Breach
MER150072525
Roche

Roche

Incidents
No explicit notable incidents reported.

FAQ

Between Merakris Therapeutics, Inc. company and Roche company, which one has the best AI Cybersecurity Score ?
Between Merakris Therapeutics, Inc. company and Roche company, which one has experienced more cyber incidents in the past ?
Between Merakris Therapeutics, Inc. company and Roche company, which one has experienced more cyber incidents this year ?
Between Merakris Therapeutics, Inc. company and Roche company, which one has experienced at least one ransomware attack ?
Between Merakris Therapeutics, Inc. company and Roche company, which one has experienced at least one data breach ?
Between Merakris Therapeutics, Inc. company and Roche company, which one has experienced at least one targeted cyberattack ?
Between Merakris Therapeutics, Inc. company and Roche company, which one has experienced at least one vulnerability ?
Between Merakris Therapeutics, Inc. company and Roche company, which one holds the most compliance certifications ?
Between Merakris Therapeutics, Inc. company and Roche company, which one holds the fewest compliance certifications ?
Between Merakris Therapeutics, Inc. company and Roche company, which one has the most subsidiaries ?
Between Merakris Therapeutics, Inc. company and Roche company, which one has the largest number of employees ?
Between Merakris Therapeutics, Inc. and Roche, which company holds both SOC 2 Type 1 certifications ?
Between Merakris Therapeutics, Inc. and Roche, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Merakris Therapeutics, Inc. or Roche ?
Which company is PCI DSS compliant - Merakris Therapeutics, Inc. or Roche ?
Between Merakris Therapeutics, Inc. and Roche, which company complies with HIPAA regulations for healthcare data ?
Between Merakris Therapeutics, Inc. and Roche, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-57100
SUMMARY

Server-side request forgery (ssrf) in Microsoft Entra Provisioning Service (SyncFabric) allows an authorized attacker to elevate privileges over a network.

PUBLISHED
Date2026-07-02
UPDATED
Date2026-07-02
RISK INFORMATION (Score: 9.9)
CVSS3
Base Score: 9.9
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
IMPACT SCORE
6
EXPLOITABILITY
3.1
CVE-2026-54998
SUMMARY

Incorrect authorization in Microsoft Exchange Online allows an authorized attacker to elevate privileges over a network.

PUBLISHED
Date2026-07-02
UPDATED
Date2026-07-02
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-45499
SUMMARY

Server-side request forgery (ssrf) in Azure OpenAI allows an authorized attacker to elevate privileges over a network.

PUBLISHED
Date2026-07-02
UPDATED
Date2026-07-02
RISK INFORMATION (Score: 9.9)
CVSS3
Base Score: 9.9
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
IMPACT SCORE
6
EXPLOITABILITY
3.1
CVE-2026-41106
SUMMARY

Url redirection to untrusted site ('open redirect') in M365 Copilot allows an unauthorized attacker to elevate privileges over a network.

PUBLISHED
Date2026-07-02
UPDATED
Date2026-07-02
RISK INFORMATION (Score: 9.3)
CVSS3
Base Score: 9.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:H/A:N
IMPACT SCORE
5.8
EXPLOITABILITY
2.8
CVE-2026-26145
SUMMARY

Improper access control in Azure Synapse allows an authorized attacker to elevate privileges over a network.

PUBLISHED
Date2026-07-02
UPDATED
Date2026-07-02
RISK INFORMATION (Score: 4.8)
CVSS3
Base Score: 4.8
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:U/C:H/I:N/A:N
IMPACT SCORE
3.6
EXPLOITABILITY
1.2